By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 73
NEW YORK (Reuters Health) – Children aged 6 months to 8 years usually require two doses of influenza vaccine, but if they were vaccinated last season they only…
NEW YORK (Reuters Health) – Children with cystic fibrosis and recently acquired Pseudomonas aeruginosa infection fare as well with either cycled or culture-based tobramycin inhalation therapy, results of…
NEW YORK (Reuters Health) – A Canadian guideline on ovarian ablation in premenopausal women with breast cancer has been endorsed by the American Society of Clinical Oncology (ASCO),…
NEW YORK (Reuters Health) – An analysis of epidemiologic data confirms that the incidence of second primary malignancies is increased after external beam radiotherapy (EBRT) for stage I…
NEW YORK (Reuters Health) – The likelihood of refractory ischemia developing in patients with non-ST-segment elevation acute coronary syndrome is reduced if they undergo early rather than deferred…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Delivery of the antispasmodic, antimuscarinic agent oxybutynin in a topical gel relieves urinary symptoms and improves health-related quality of life in women with…
NEW YORK (Reuters Health) – Despite having a favorable effect on cytokine levels, perioperative methylprednisolone does not reduce the incidence of lung injury after pulmonary thromboendarterectomy (PTE), according…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of…
NEW YORK (Reuters Health) – Intra-aortic balloon counterpulsation (IABC) to augment blood flow before and for 12 hours after percutaneous coronary intervention (PCI) does not reduce infarct size…
